Processa Pharmaceuticals, Inc. Common — Grafico, Quotazione e Notizie (NASDAQ:PCSA) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 7.6343 M
Employee 12
Founded 2011
CEO N/A
Website www.processapharmaceuticals.com
Headquarter Delaware, United States
FIGI BBG003MN5ZP8
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

7.63 M Capitalizzazione di mercato

Rapporto prezzo/utili

-0.28

Rapporto prezzo/fatturato

188.54

Notizie

Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AAR (NYSE:AIR), Alpha Modus Holdings (NASDAQ:AMOD)

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study

PCSA Stock Soars on Upbeat Clinical Update From Breast Cancer Study

Why MillerKnoll Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Akanda (NASDAQ:AKAN), Actelis Networks (NASDAQ:ASNS)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

Here’s Why Penny Stock Processa Pharmaceuticals (PCSA) Is Exploding Today - TipRanks.com

Il titolo di Processa Pharmaceuticals sale dopo risultati promettenti del farmaco anticancro

Processa Pharmaceuticals stock soars after cancer drug shows promising results

Processa riporta dati preliminari positivi per terapia contro il cancro

Processa reports positive preliminary data for cancer therapy

Processa Pharmaceuticals annuncia un reverse stock split di 1 a 25 efficace questa settimana

Processa Pharmaceuticals announces 1-for-25 reverse stock split effective this week